Evidence-led articles exploring weight loss medications, including GLP-1 treatments like Wegovy and Mounjaro, how they work, and what to consider when they're prescribed responsibly.
Back to Health Hub
Wegovy and Mounjaro are two of the most talked-about weight loss medications today. Learn how they work, what makes them different, and why provider pricing can vary.
Prescription Weight-Loss Medications vs Supplements: What’s the Difference?
A balanced, UK-focused overview of prescription weight loss medications—how they work, who they’re for, expected results, side effects, and how to access treatment safely.
Weight loss medications support the body’s natural appetite and hormone systems. Learn how treatments like Wegovy and Mounjaro work, their benefits, limitations, and what to expect.
Thinking about starting Wegovy for weight loss? Learn how it works, what to expect, potential side effects, and how to access treatment safely in the UK.
GLP-1 medications such as Wegovy and Mounjaro support weight loss by regulating appetite and fullness. Learn how they work, what to expect, and how they fit into treatment.
Mounjaro is a newer weight loss medication with a dual hormone approach. Learn how it works, how it compares to Wegovy, and what to expect in the UK.
Are weight loss medications like Wegovy and Mounjaro safe? This guide explains the evidence, side effects, and how safety is assessed in the UK.
Not everyone is suitable for weight loss medication. Learn who may benefit from treatments like Wegovy and Mounjaro, and how eligibility is assessed in the UK.
Weight loss is not just about willpower. This article explains the biology of obesity and why medications like Wegovy and Mounjaro support long term weight management.
Mounjaro can cause side effects, particularly when starting treatment. Learn what is common, what is less common, and how to manage symptoms safely.
Wegovy can cause side effects, especially when starting treatment. Learn what is common, what is less common, and how to manage symptoms safely in the UK.